Trials / Unknown
UnknownNCT05187104
Treatment of Age-related Macular Degeneration Using Retinal Stem and Progenitor Cells
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Treatment of age-related macular degeneration using retinal stem and progenitor cells
Detailed description
The aim of the project is to develop a biomedical cell product based on retinal pigment epithelium cells for highly effective treatment age-related macular degeneration; to conduct the clinical trials of the biomedical cell product in the treatment of age-related macular degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Cultured retinal stem and progenitor cells | Cultured retinal stem and progenitor cells injected subretinally |
| OTHER | Standard treatment according to the clinical protocols | Standard treatment of age-related macular degeneration according to the clinical protocols |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2022-01-11
- Last updated
- 2022-09-14
Locations
1 site across 1 country: Belarus
Source: ClinicalTrials.gov record NCT05187104. Inclusion in this directory is not an endorsement.